Search Result "levodopa"
The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinsons Disease
Journal: Current Clinical Pharmacology
Volume: 2 Issue: 3 Year: 2007 Page: 234-243
Author(s): Soo-Peang Khor, Ann Hsu
Relationship Between Gut Bacteria and Levodopa Metabolism
Journal: Current Neuropharmacology
Volume: 21 Issue: 7 Year: 2023 Page: 1536-1547
Author(s):
Skin Lipid Synthesis Inhibition: A Possible Means for Enhancing Percutaneous Delivery of Levodopa
Journal: Current Drug Delivery
Volume: 1 Issue: 4 Year: 2004 Page: 397-403
Author(s): Kumar Babita, Ashok Kumar Tiwary
Revisiting the Medical Management of Parkinsonâs Disease: Levodopa versus Dopamine Agonist
Journal: Current Neuropharmacology
Volume: 14 Issue: 4 Year: 2016 Page: 356-363
Author(s): Jinglin Zhang,Louis Chew-Seng Tan
Effect of Surface Charge Density of a w/o/w Emulsion on the Brain Targetingof Levodopa in Rats for the Treatment of Parkinsonâs Disease
Journal: Drug Delivery Letters
Volume: 12 Issue: 4 Year: 2022 Page: 302-310
Author(s): Chandir C. Ramani,R. Jayachandra Babu
Levodopa in Parkinsonâs Disease: Current Status and Future Developments
Journal: Current Neuropharmacology
Volume: 16 Issue: 8 Year: 2018 Page: 1239-1252
Author(s): Nicola Tambasco,Michele Romoli,Paolo Calabresi
Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 9 Year: 2016 Page: 874-883
Author(s): Zsófia Majláth,József Toldi,Ferenc Fülöp,László Vécsei
Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinsonâs Disease: A Systematic Review
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 18 Issue: 4 Year: 2019 Page: 317-325
Author(s): Mahmoud A. Ebada,Souad Alkanj,Mohamed Ebada,Ahmed H. Abdelkarim,Ahmed Diab,Mohamed A.E. Aziz,Ahmed M. Soliman,Notila Fayed,Eshak I. Bahbah,Ahmed Negida
Levodopa Therapy for Parkinson's Disease: History, Current Status and Perspectives
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 19 Issue: 8 Year: 2020 Page: 572-583
Author(s): Helle Bogetofte,Arezo Alamyar,Morten Blaabjerg,Morten Meyer
Double-Blind, Placebo-Controlled, Randomized Phase I/IIa Study (Safety and Efficacy) with Buspirone/Levodopa/Carbidopa (SpinalonTM) in Subjects with Complete AIS A or Motor-Complete AIS B Spinal Cord Injury
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 12 Year: 2017 Page: 1789-1804
Author(s): Mohan Radhakrishna,Inge Steuer,Francois Prince,Mary Roberts,David Mongeon,Maryam Kia,Sasha Dyck,Gilbert Matte,Mario Vaillancourt,Pierre A. Guertin